Table 7.
Benefit/risk ratio for LAI FGA and LAI SGA in schizophrenia
| Prevention of psychotic recurrence | |
|---|---|
|
1
st
line treatment |
Risperidone LAI |
| 2 nd line treatment | Olanzapine pamoate |
| Haloperidol decanoate | |
| Zuclopenthixol decanoate | |
| Flupentixol decanoate | |
| Fluphenazine decanoate | |
| Pipotiazine palmitate |